Medico Remedies Limited has informed the Exchange regarding Appointment of M/s. Shah Shroff & Associates as Other of the company w.e.f. September 30, 2025.
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medico Remedies Limited announced the audited financial results for FY25 along with several board decisions from its May 8, 2025 meeting. Revenue from operations grew modestly to Rs. 150.94 crore from Rs. 144.92 crore in FY24, while profit after tax rose about 22% to Rs. 10.09 crore from Rs. 8.29 crore. Basic EPS improved to Rs. 1.22 from Rs. 1.00. The previous statutory auditors, VJ Shah & Co, completed their term and ceased after the 31st AGM, and Shah Shroff & Associates were appointed as new statutory auditors for a 5-year term (subject to shareholder approval). Mr. Haresh Sanghvi was also appointed as secretarial auditor for five years from FY26 to FY30. The auditor's report carried an unmodified (clean) opinion.
Routine auditor rotation at end of term with no governance red flags; clean audit opinion and healthy profit growth (~22% YoY) are mildly positive for shareholders, though revenue growth was modest at ~4%.